A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

NCT05669950 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Adrenal Hyperplasia

Interventions

DRUG: Lu AG13909

Sponsor

H. Lundbeck A/S